started · updated
Researchers discover molecule that may protect vision from diabetes
An international research collaboration has identified a human molecule, the peptide Ac2-26, which shows potential in preventing diabetic retinopathy. The study, published in the journal Biomedicine & Pharmacotherapy, involved scientists from the Federal University of São Paulo (Unifesp), the São Paulo State University (Unesp), and the University of Colorado Anschutz.
Diabetic retinopathy affects more than 22% of people with diabetes globally. The condition is driven by high glucose levels that cause inflammation, oxidative stress, and damage to retinal blood vessels and neurons, potentially leading to permanent blindness.
In laboratory tests using human retina models and three-dimensional organoids known as “miniretinas,” the Ac2-26 peptide, derived from the anti-inflammatory protein Annexin A1, demonstrated the ability to reduce inflammation and oxidative stress. The peptide also protects mitochondria, preventing the premature death of nerve cells exposed to high glucose levels. This discovery suggests a new strategic approach for ophthalmological treatments, particularly in the early stages of the disease.
Entities
Biomedicine & Pharmacotherapy · Federal University of São Paulo · São Paulo State University · University of Colorado Anschutz